<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146456">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02114086</url>
  </required_header>
  <id_info>
    <org_study_id>ROKSM 01/12</org_study_id>
    <secondary_id>KMünsterlingen</secondary_id>
    <nct_id>NCT02114086</nct_id>
  </id_info>
  <brief_title>IORT-Boost-Study, Prospective Observational Study for Intraoperative Radiotherapy of the Breast as a Boost</brief_title>
  <official_title>Prospective Observational Study for Intraoperative Radiotherapy (IORT) of the Breast as a Boost</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Münsterlingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Münsterlingen</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators observe the investigation, whether the new method for
      Boost-Irradiation with the Intrabeam Device of Zeiss Germany influences local recurrence,
      acute and late effects of Radiotherapy, overall survival, quality of life and cosmesis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">February 2026</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>number of Participants with local recurrence histologically proven</measure>
    <time_frame>up to 10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Recurrence of breast cancer proven by histology</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>observation of acute and late effects of Radiotherapy</measure>
    <time_frame>up to 10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>acute effects of Radiotherapy are assessed by Common Toxicity Criteria for Adverse Effects (CTCAE Version 4.0) and late effects of Radiotherapy are assessed by Late Effects Normal Tissue Subjective Objective Management Analysis (LENT-SOMA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>up to 10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>The number of Patients who died is assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>up to 10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of life is assessed by European Organization for Research and Treatment of Cancer (EORTC) quality of life questionnaires (QLQ) cancer modul (C30) EORTC-QLQ-C30 version 3.0 and breast cancer modul (BR23) EORTC-QLQ-BR23</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cosmesis</measure>
    <time_frame>up to 10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Cosmesis is assessed by Photographs and evaluated automatically.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>observation of influence of smoking</measure>
    <time_frame>up to 10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients are asked how many cigarettes they smoke.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Adverse Effect of Radiation Therapy</condition>
  <arm_group>
    <arm_group_label>breast cancer</arm_group_label>
    <description>observation of intraoperative radiotherapy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        women with breast cancer breast-conserving therapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women with histologically proven unifocal ductal-invasive or other histology of
             breast-cancer, size of tumor &lt; or = 3.5 cm

          -  written informed consent

          -  ability of compliance

          -  full contra cutal capability

        Exclusion Criteria:

          -  missing written informed consent

          -  no compliance
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christiane Reuter, Dr. med.</last_name>
    <role>Study Director</role>
    <affiliation>Kantonsspital Münsterlingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christiane Reuter, Dr. med.</last_name>
    <phone>+41 71 686 11 11</phone>
    <email>christiane.reuter@stgag.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>KMünsterlingen</name>
      <address>
        <city>Münsterlingen</city>
        <state>Thurgau</state>
        <zip>8596</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christiane Reuter, Dr. med.</last_name>
      <phone>+41 71 686 11 11</phone>
      <email>christiane.reuter@stgag.ch</email>
    </contact>
    <investigator>
      <last_name>Hans Reichardt, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christiane Reuter, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad WJ, Oei SB, Wárlám-Rodenhuis CC, Pierart M, Collette L. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007 Aug 1;25(22):3259-65. Epub 2007 Jun 18.</citation>
    <PMID>17577015</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 14, 2014</lastchanged_date>
  <firstreceived_date>September 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Observational Study</keyword>
  <keyword>intraoperative Radiation of Breast Cancer</keyword>
  <keyword>early and late effects of radiation</keyword>
  <keyword>cosmesis and quality of life</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
